111
Views
22
CrossRef citations to date
0
Altmetric
Review

Cerebrospinal fluid: identification of diagnostic markers for schizophrenia

&
Pages 209-216 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

İbrahim Gundogmus, Ayhan Algul, Abdulkadir Karagöz & Murat Kıyançiçek. (2019) PDW and RDW are new parameters for bipolar episodes and unipolar depression. Psychiatry and Clinical Psychopharmacology 29:4, pages 520-526.
Read now

Articles from other publishers (21)

Toshiyuki Mizui, Kotaro Hattori, Sayuri Ishiwata, Shinsuke Hidese, Sumiko Yoshida, Hiroshi Kunugi & Masami Kojima. (2019) Cerebrospinal fluid BDNF pro-peptide levels in major depressive disorder and schizophrenia. Journal of Psychiatric Research 113, pages 190-198.
Crossref
Josefin Hjärpe, Erik Söderman, Dimitrios Andreou, Göran C. Sedvall, Ingrid Agartz & Erik G. Jönsson. (2018) No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals. Psychiatry Research 263, pages 30-34.
Crossref
Sheng-Yu Lee, Tzu-Yun Wang, Shiou-Lan Chen, Yun-Hsuan Chang, Po-See Chen, San-Yuan Huang, Nian-Sheng Tzeng, Liang-Jen Wang, I. Hui Lee, Kao Chin Chen, Yen Kuang Yang, Yi-Hsin Yang, Ru-Band Lu & Cheng-Sheng Chen. (2016) The correlation between plasma brain-derived neurotrophic factor and cognitive function in bipolar disorder is modulated by the BDNF Val66Met polymorphism. Scientific Reports 6:1.
Crossref
Mahlon A. Collins, Jiyan An, Danielle Peller & Robert Bowser. (2015) Total protein is an effective loading control for cerebrospinal fluid western blots. Journal of Neuroscience Methods 251, pages 72-82.
Crossref
Madhu Kalia & Jorge Costa e Silva. (2015) Biomarkers of psychiatric diseases: Current status and future prospects. Metabolism 64:3, pages S11-S15.
Crossref
S.-Y. Lee, S.-L. Chen, Y.-H. Chang, P.-S. Chen, S.-Y. Huang, N.-S. Tzeng, C.-L. Wang, L.-J. Wang, I.-H. Lee, T.-Y. Wang, K.-C. Chen, Y.-K. Yang, J.-S. Hong & R.-B. Lu. (2015) Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention. Acta Psychiatrica Scandinavica 131:2, pages 120-128.
Crossref
Giuseppina Maccarrone, Claudia Ditzen, Alexander Yassouridis, Christiane Rewerts, Manfred Uhr, Mathias Uhlen, Florian Holsboer & Christoph W. Turck. (2013) Psychiatric patient stratification using biosignatures based on cerebrospinal fluid protein expression clusters. Journal of Psychiatric Research 47:11, pages 1572-1580.
Crossref
Laura W. Harris, Paul C. Guest, Matthew T. Wayland, Yagnesh Umrania, Divya Krishnamurthy, Hassan Rahmoune & Sabine Bahn. (2013) Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies. Psychoneuroendocrinology 38:6, pages 752-766.
Crossref
Yaling Yang, Keith H. Nuechterlein, Owen R. Phillips, Boris Gutman, Florian Kurth, Ivo Dinov, Paul M. Thompson, Robert F Asarnow, Arthur W. Toga & Katherine L. Narr. (2011) Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: A tensor‐based morphometry study. Human Brain Mapping 33:9, pages 2081-2091.
Crossref
Nenad Vasic, Bernhard J. Connemann, Robert C. Wolf, Hayrettin Tumani & Johannes Brettschneider. (2011) Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?. European Archives of Psychiatry and Clinical Neuroscience 262:5, pages 375-391.
Crossref
Anilkumar Pillai, Davide Bruno, Antero S. Sarreal, Raymundo T. Hernando, Leslie A. Saint-Louis, Jay Nierenberg, Stephen D. Ginsberg, Nunzio Pomara, Pankaj D. Mehta, Henrik Zetterberg, Kaj Blennow & Peter F. Buckley. (2012) Plasma BDNF Levels Vary in Relation to Body Weight in Females. PLoS ONE 7:7, pages e39358.
Crossref
Ajaykumar N Sharma, Khalid M Elased & James B Lucot. (2012) Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice . Journal of Psychopharmacology 26:5, pages 724-732.
Crossref
Hong I Wan, Holly Soares & Jeffrey F Waring. (2012) Use of cerebrospinal fluid biomarkers in clinical trials for schizophrenia and depression. Biomarkers in Medicine 6:1, pages 119-129.
Crossref
Nadine Correia Santos, Patrício Costa, Dina Ruano, António Macedo, Maria João Soares, José Valente, Ana Telma Pereira, Maria Helena Azevedo & Joana Almeida Palha. (2012) Revisiting Thyroid Hormones in Schizophrenia. Journal of Thyroid Research 2012, pages 1-15.
Crossref
Benjamin Pickard. (2011) Progress in defining the biological causes of schizophrenia. Expert Reviews in Molecular Medicine 13.
Crossref
Dorothy G. Flood, Gerard J. Marek & Michael Williams. (2011) Developing predictive CSF biomarkers—A challenge critical to success in Alzheimer's disease and neuropsychiatric translational medicine. Biochemical Pharmacology 81:12, pages 1422-1434.
Crossref
Roanna J. Hall, Susan D. Shenkin & Alasdair M.J. MacLullich. (2011) A Systematic Literature Review of Cerebrospinal Fluid Biomarkers in Delirium. Dementia and Geriatric Cognitive Disorders 32:2, pages 79-93.
Crossref
Ajaykumar N. Sharma, Khalid M. Elased, Teresa L. Garrett & James B. Lucot. (2010) Neurobehavioral deficits in db/db diabetic mice. Physiology & Behavior 101:3, pages 381-388.
Crossref
George Issa, Christina Wilson, Alvin V. TerryJr.Jr. & Anilkumar Pillai. (2010) An inverse relationship between cortisol and BDNF levels in schizophrenia: Data from human postmortem and animal studies. Neurobiology of Disease 39:3, pages 327-333.
Crossref
Anilkumar Pillai, Anvita Kale, Sadhana Joshi, Nilesh Naphade, M. S. V. K. Raju, Henry Nasrallah & Sahebarao P. Mahadik. (2009) Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. The International Journal of Neuropsychopharmacology 13:04, pages 535.
Crossref
Mousumi Debnath, Godavarthi B.K.S. Prasad & Prakash S. BisenMousumi Debnath, Godavarthi B.K.S. Prasad & Prakash S. Bisen. 2010. Molecular Diagnostics: Promises and Possibilities. Molecular Diagnostics: Promises and Possibilities 347 382 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.